China: GlaxoSmithKline plc Is Bribing Officials – ValueWalk Premium
GlaxoSmithKline

China: GlaxoSmithKline plc Is Bribing Officials

GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives have confessed to charges of bribery and tax law violations, according to China’s security ministry.

GlaxoSmithKline Executives Suspected Of Offering Bribes

GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives are suspected of offering bribes to officials and doctors to enhance their product sales in China.

According to Chinese security ministry,

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0